A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities

A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities

Background: Data suggest that approximately 50,000 adults with learning disabilities (LDs) in England and Wales are currently prescribed antipsychotic medication. Illness in this population is common, including significant rates of challenging behaviour and mental illness, but there is particular co...

Full description

Bibliographic Details
Main Authors: Rachel McNamara, Elizabeth Randell, David Gillespie, Fiona Wood, David Felce, Renee Romeo, Lianna Angel, Aude Espinasse, Kerry Hood, Amy Davies, Andrea Meek, Katy Addison, Glyn Jones, Paul Deslandes, David Allen, Martin Knapp, Ajay Thapar, Michael Kerr
Format: Article
Language:English
Published: NIHR Journals Library 2017-08-01
Series:Health Technology Assessment
Subjects:
antipsychotic medication
drug reduction
learning disability
adults
randomised controlled trial
Online Access:https://doi.org/10.3310/hta21470

Similar Items

Similar Items